(NasdaqGM:RZLV), NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, announces that the Company will report second half and full year 2024 financial results on Thursday, April 24, 2025 after market close. Rezolve Ai's management team will then host a live conference call and webcast […]

(TSX:PRN),(NASDAQ:PROF), TORONTO, April 17, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Profound management will host

(NASDAQ:MCHP), CHANDLER, Ariz., April 17, 2025 (GLOBE NEWSWIRE) — The JANS qualification represents the highest level of screening and acceptance requirements, ensuring the superior performance, quality and reliability of discrete semiconductors for aerospace, defense and spaceflight applications. Microchip Technology (Nasdaq: MCHP) today announces its completion of its family of radiation-hardened (rad-hard) power MOSFETs to the

SAN JOSE, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Beachhead Solutions, provider of cloud-managed PC & mobile device encryption, security, and data access control for Managed Service Providers (MSPs), today announced the version 1.0 launch of ComplianceEZ. The powerful new tool, integrated into the BeachheadSecure for MSPs platform at no additional cost, transforms how MSPs

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) — Cove Capital LLC (“Cove” or the “Company”), a company at the forefront of developing critical minerals projects and advanced downstream technologies globally, is proud to announce the appointment of The Hon. Arthur Sinodinos AO, former Australian Ambassador to the United States, as a Special Advisor. Ambassador Sinodinos

(NasdaqGM:ACTU), CHICAGO and FORT WORTH, Texas, April 17, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3B), today announced that data on elraglusib in advanced salivary gland

(TSX:DBM),(TSX:DBM-NT), THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman” or “the Company”) (TSX: DBM) is pleased to announce that it will

(NASDAQ:HOWL), WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions, today announced the appointment of Steven Bloom as Chief Business

(NASDAQ:ECOR), ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that new data presented at the 2025 International Brain Injury Association World Congress highlights the effectiveness of gammaCore(R) non-invasive vagus nerve stimulation (nVNS) in treating concussive symptoms associated with mild traumatic brain injury

(NASDAQ:DXR), WellStar Health System to Highlight New BVA-Driven Strategy That Significantly Reduces Kidney Injury Following LVAD Implantation Oak Ridge, TN, April 17, 2025 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will be exhibiting at the MedAxiom CV Transforum Spring'25 Conference being held at the